Board of Directors

Bob Croce

Chairman of the Board

Mr. Croce joined Svelte’s Board of Directors following a 36 year career at Johnson & Johnson where he held a series of senior positions, culminating with 12 years as Company Group Chairman.

Read Background

Jack Darby

President and CEO

Mr. Darby has 20 years of experience in the medical device industry, most of those in the interventional cardiovascular space. Prior to joining Svelte Medical Systems in 2012, Mr. Darby was the business unit head of Bayer Interventional.

Read Background

Robert J. Flanagan

President, Clark Enterprises, Inc.

Mr. Flanagan is President of Clark Enterprises, overseeing the acquisition, management and development of new investment opportunities.

Read Background

Somu Subramaniam

Managing Partner, New Science Ventures, LLC

Mr. Subramaniam is the Co-Founder and Managing Partner of New Science Ventures, serving on the Board of Directors of Achronix Semiconductor Corporation, Alexar Therapeutics, Ario Pharmaceuticals, Cambridge Epigenetix, Dali Wireless, Dezima Pharma, Juventas Therapeutics, Oxyrane, Resolve Therapeutics, TigerText, Vaultive, and iCAD.

Read Background

Richard Dakers

Independent Director

Mr. Dakers is President of Daker Enterprises, overseeing the acquisition, management and development of new investment opportunities.

Read Background